Skip to main content
. 2016 May 6;7(24):36266–36279. doi: 10.18632/oncotarget.9200

Figure 1. Distribution of TP53 somatic mutations in lower-risk MDS patients.

Figure 1

(A) Frequency of TP53 mutations in lower-risk MDS patients with and without del(5q). (B) Pie chart representing the different TP53 mutation types detected in entire patient cohort.